Pia Campagna

Translational PhD Candidate & HealthTech Startup Enthusiast

Pia applies genomic methodologies to improve multiple sclerosis prognostics & inform the individualisation of multiple sclerosis management.

01

About

Pia is a second-year PhD candidate in the Department of Neuroscience, Central Clinical School, Monash University in Melbourne, Australia.

She has a strong interest in start-ups that are disrupting healthcare with technology. She is a Startmate Student Fellow (W21) and writes about the HealthTech startup ecosystem (among other things) on her blog.

In her spare time, Pia loves reading (mostly fiction, but you'll soon find non-fiction book summaries on her blog), cooking (read: eating) and learning about things she is curious about! She does not run marathons.

01

PhD Thesis

Pia's thesis consists of three main studies

  • The pharmacogenomics of disease-modifying therapies in relapsing-remitting MS

  • Whole-blood DNA methylation patterns as a prognostic marker in relapse-onset MS

  • The molecular impact of pregnancy in women with MS

02

Science Communication

Triple R’s Eienstein A Go-Go #20phdsin20mins
Pia communicated her PhD project on multiple sclerosis pharmacogenomics to a general, non-expert audience in just two minutes. Triple R has over 440,000 weekly listeners and 7,000 weekly podcast downloads. Listen here

04

Leadership

Pia is passionate about broadening the social and professional networks of Australian graduate students to improve the graduate research experience, increase networking and collaboration during PhDs and improve post-doc opportunities. For this reason, she has multiple leadership positions in 2021:

Pia is also a mentor with the New York Academy of Sciences, Monash University Alumni to Student Mentoring Program and BrainStem.

05

Publications

  • Zhong M, van der Walt A, Campagna MP, et al. The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics. 2020 Oct;17(4):1768-1784. DOI: 10.1007/s13311-020-00950-2.

  • Rath L, Campagna MP, Stankovich J, et al., Assessing Patient Preference: Preferred time and location of infusible therapies in Multiple Sclerosis and Neuroimmunological disorders. Internat Journal of MS Care 2020 [accepted 27 Oct 2020]. https://doi.org/10.7224/1537-2073.2020-075

06

Presentations

Pia has presented at multiple regional, one national and one international conferences and symposiums

  • 2021 GeneMappers Conference. Title: Whole-blood methylation as a prognostic biomarker in multiple sclerosis. Lightning presentation speaker selected from abstract Awarded 1st Place for Best Student Lightning Presentation

  • 2021 Australian Society of Medical Research (ASMR) Victorian Symposium. Title: Whole-blood methylation as a prognostic biomarker in multiple sclerosis. Speaker selected from abstract Awarded 1st Place for Best Oral Presentation

  • 2021 International Society for Computational Biology Great Lakes Bioinformatics Conference. Whole-blood methylation as a prognostic biomarker in multiple sclerosis. Platform speaker selected from abstract

  • 2020 Monash University Central Clinical School Graduate Research Symposium. Using DNA methylation to predict disease severity in multiple sclerosis. Speaker selected from abstract. Awarded 2nd Place for Best Oral Presentation & Committee Choice for Best Oral Presentation

  • Nov 2020 Monash University Neuroscience in a Flash. Using DNA methylation to predict disease severity in multiple sclerosis. Speaker selected from abstract

07

Posters

  • 2021 Australian Epigenetics Conference. Using DNA methylation to predict disease severity in multiple sclerosis. Poster presenter selected from abstract

  • 2020 Students of Brain Research (SOBR) Symposium. Using DNA methylation to predict disease severity in multiple sclerosis. Poster presenter selected from abstract

  • 2019 Alfred Health Research Week. Preliminary Genetic Predictors of Fingolimod Response in Relapse-Remitting Multiple Sclerosis Patients of European Descent. Poster presenter selected from abstract

Contact

Reach out to Pia with any comments, questions or opportunities

© Untitled. All rights reserved.

Thank you!